SGLT2i in the Treatment of Heart Failure
CSCS Virtual Lecture Series
Dr. Subodh Verma provides his expert opinion on heart failure medical management in this segment of the CSCS lecture series.
Objectives:
- To discuss the rationale of using SGLT2i in the prevention and treatment of heart failure
- To discuss the completed large outcome trials of SGLTi in HFrEF and HFpEF
- To discuss the changes to clinical practice guidelines
Presented March 10, 2022.